Cargando…
Daptomycin for the treatment of osteomyelitis and orthopaedic device infections: real-world clinical experience from a European registry
Osteomyelitis is a serious infection predominantly caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Orthopaedic device-related infections are complex and require a careful combination of surgical intervention and antimicrobial therapy. Daptomycin, a cyc...
Autores principales: | Malizos, K., Sarma, J., Seaton, R. A., Militz, M., Menichetti, F., Riccio, G., Gaudias, J., Trostmann, U., Pathan, R., Hamed, K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710650/ https://www.ncbi.nlm.nih.gov/pubmed/26563898 http://dx.doi.org/10.1007/s10096-015-2515-6 |
Ejemplares similares
-
Evaluation of Effectiveness and Safety of High-Dose Daptomycin: Results from Patients Included in the European Cubicin(®) Outcomes Registry and Experience
por: Seaton, R. Andrew, et al.
Publicado: (2015) -
Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORE(SM) database
por: Seaton, R. Andrew, et al.
Publicado: (2013) -
Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORE(SM) Registry
por: Gonzalez-Ruiz, Armando, et al.
Publicado: (2015) -
Real-World Treatment of Complicated Skin and Soft Tissue Infections with Daptomycin: Results from a Large European Registry (EU-CORE)
por: Cogo, Alberto, et al.
Publicado: (2015) -
Daptomycin for the Treatment of Infective Endocarditis: Results from European Cubicin(®) Outcomes Registry and Experience (EU-CORE)
por: Guleri, Achyut, et al.
Publicado: (2015)